The health and safety of using e-cigarette products (vaping)
have
been challenging to assess and further regulate due to their complexity.
Inhaled e-cigarette aerosols contain chemicals with under-recognized
toxicological profiles, which could influence endogenous processes
once inhaled. We urgently need more understanding on the metabolic
effects of e-cigarette exposure and how they compare to combustible
cigarettes. To date, the metabolic landscape of inhaled e-cigarette
aerosols, including chemicals originated from vaping and perturbed
endogenous metabolites in vapers, is poorly characterized. To better
understand the metabolic landscape and potential health consequences
of vaping, we applied liquid chromatography–mass spectrometry
(LC-MS) based nontargeted metabolomics to analyze compounds in the
urine of vapers, cigarette smokers, and nonusers. Urine from vapers
(n = 34), smokers (n = 38), and
nonusers (n = 45) was collected for verified LC-HRMS
nontargeted chemical analysis. The altered features (839, 396, and
426 when compared smoker and control, vaper and control, and smoker
and vaper, respectively) among exposure groups were deciphered for
their structural identities, chemical similarities, and biochemical
relationships. Chemicals originating from e-cigarettes and altered
endogenous metabolites were characterized. There were similar levels
of nicotine biomarkers of exposure among vapers and smokers. Vapers
had higher urinary levels of diethyl phthalate and flavoring agents
(e.g., delta-decalactone). The metabolic profiles featured clusters
of acylcarnitines and fatty acid derivatives. More consistent trends
of elevated acylcarnitines and acylglycines in vapers were observed,
which may suggest higher lipid peroxidation. Our approach in monitoring
shifts of the urinary chemical landscape captured distinctive alterations
resulting from vaping. Our results suggest similar nicotine metabolites
in vapers and cigarette smokers. Acylcarnitines are biomarkers of
inflammatory status and fatty acid oxidation, which were dysregulated
in vapers. With higher lipid peroxidation, radical-forming flavoring,
and higher level of specific nitrosamine, we observed a trend of elevated
cancer-related biomarkers in vapers as well. Together, these data
present a comprehensive profiling of urinary biochemicals that were
dysregulated due to vaping.